Outcomes of Splenectomy During Primary Cytoreductive Surgery in Ovarian Cancer
نویسندگان
چکیده
منابع مشابه
Splenectomy during secondary cytoreductive surgery for epithelial ovarian cancer.
Splenic metastasis from ovarian cancer is unusual. Most splenic metastases are encountered in the setting of widespread visceral metastases. We present 6 cases of splenic metastasis of epithelial ovarian cancer. Three cases underwent a splenectomy as a part of interval debulking surgery, and the rest received a splenectomy as a surgery for recurrent disease. The splenectomies were well-tolerate...
متن کاملCytoreductive surgery in ovarian cancer
As the overall prognosis for patients with ovarian cancer is poor, the management of this condition should be restricted to expert multi-disciplinary teams in gynaecological oncology. Apparent early stage ovarian cancer requires accurate and complete staging so that potential sites for metastases are not missed. Omitting adequate staging may have significant consequences including a negative im...
متن کامل3. Cytoreductive surgery for ovarian cancer
(1) Surgery for diagnostic purposes: This kind of surgery could be performed at any time in the course of ovarian cancer (e.g. to get a histological diagnosis). Second-look surgery belongs to this group of procedures. It is an operation performed in patients who are clinically free of disease after the completion of a defined course of chemotherapy with the purpose to confirm the response statu...
متن کاملCytoreductive surgery in the management of ovarian cancer.
The standard management for previously untreated advanced-stage epithelial ovarian cancer is optimum cytoreductive surgery followed by aggressive cytotoxic chemotherapy. This approach is based on a retrospective review of a single-institution experience published more than 30 years ago and has yet to be confirmed in a prospective randomized trial. Many subsequent studies have supported the obse...
متن کاملRole of cytoreductive surgery in recurrent ovarian cancer.
Cytoreductive surgery is well established in patients with primary ovarian cancer. The benefit of surgery in patients with recurrent ovarian cancer remains a controversial matter. There is a large heterogeneity in surgical results published in the literature, possibly caused by infrastructure, surgeons' philosophy and belief in adding various surgical skills. This might also be a result of diff...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the American College of Surgeons
سال: 2015
ISSN: 1072-7515
DOI: 10.1016/j.jamcollsurg.2015.07.227